Biotech veteran Art Krieg postpones retirement to build an unorthodox drug startup
BioPharma
Source: biopharmadive.com
Stay updated with breaking news from Checkmate Pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biotech stocks offers the potential for significant returns driven by breakthrough discoveries and advancements in healthcare, agriculture, and other industries.
Fourth quarter 2023 revenues increased 1% to $3.43 billion versus fourth quarter 2022; excluding RonapreveTM, revenues increased 14%Full year 2023 revenues increased 8% to $13.12 billion versus full...